Skip to content

Depression: all studies

Page 707 of 1,036: studies 7,061 to 7,070 of 10,358, newest first. Back to the depression overview

Research

Effect of mindfulness-based stress reduction in patients with acute myocardial infarction after successful primary percutaneous coronary intervention: a retrospective study.

BMC cardiovascular disorders June 23, 2023 Jun-Jie Gu, Xiao-Shan Tong, Sha-Sha Meng et al.

This study aimed to examine the effects of mindfulness-based stress reduction (MBSR) in patients with acute myocardial infarction (AMI) after primary percutaneous coronary intervention (PPCI). A retrospective study was conducted with data collected from AMI patients who underwent successful PPCI. The study included 61 cases that received 8-week MBSR intervention (MBSR group) and 61 cases that...

DOI: 10.1186/s12872-023-03346-0 (opens in new tab) Full text (opens in new tab) Acute myocardial infarction Mindfulness-based stress reduction

Immediate impact of Mindfulness-Based Cognitive Therapy (MBCT) among women with breast cancer: a systematic review and meta-analysis

BMC Women's Health June 22, 2023 Yun-Chen Chang, T. Tseng, Gen-Min Lin et al.

Background Mindfulness-based cognitive therapy (MBCT) may have positive physiological and psychological benefits for breast cancer survivors. However, few studies involved a combination of the relevant literatures to confirm the effects. Methods Our study included randomized controlled trials (RCTs) and non-RCTs comparing interventions of MBCT and control protocols for alleviation of symptoms...

KLASIKINIŲ PSICHODELIKŲ VEIKIMO MECHANIZMAI, BIOLOGINĖS SAVYBĖS IR TERAPINĖ NAUDA PACIENTAMS, TURINTIEMS PSICHIKOS SUTRIKIMŲ

Health Sciences June 22, 2023 Rapolas Šalaševičius, Gabrielė Pakriaušytė

Klasikiniai psichodelikai – tai natūralios (psilocibi­nas) arba sintetinės (LSD) medžiagos, stimuliuojančios 5-HT2A receptorius ir sukeliančios pakitusias regos, klau­sos, kognityvines ar nuotaikos būsenas. Šios medžiagos vis dažniau patraukia mokslo tyrėjų bendruomenės dė­mesį dėl jų potencialios naudos pacientams, sergantiems įvairaus spektro psichikos sutrikimais. Atlikę literatūros apžvalgą...

MINDFULNESS TRAINING – EFFECT ON ADULTS WITH ADHD AND DEPRESSIVE SYMPTOMS AND THE ROLE OF DIGITAL TECHNOLOGIES

Journal Health and Technology - JHT June 21, 2023 Ioanna Moraiti, Anestis Fotoglou, Athanasios Drigas 5 citations

Nowadays, more and more people are faced with symptoms of depression. This literature review focuses on adults with ADHD and depressive symptoms and presents the therapeutic technique of mindfulness and its benefits. The purpose of the paper was to add another method of reducing the symptoms of people who suffer from such difficulties in their daily lives. At the same time, the role of new...

Effectiveness of Mindfulness-Based Cognitive Therapy in reducing psychological distress and improving sleep in patients with Inflammatory Bowel Disease: study protocol for a multicentre randomised controlled trial (MindIBD).

BMC Psychology June 19, 2023 Milou M Ter Avest, Annelieke S M Van Velthoven, Anne E. M. Speckens et al.

Many patients with Inflammatory Bowel Diseases (IBD) suffer from psychological distress, fatigue and sleep disturbances, which are associated with reduced quality of life (QoL) and increased societal costs. Only limited psychosocial treatment options are available. As Mindfulness-Based Cognitive Therapy (MBCT) has demonstrated to improve psychological distress, QoL and sleep in other...

DOI: 10.1186/s40359-023-01127-0 (opens in new tab) Full text (opens in new tab) Cost-effectiveness Crohn’s disease Inflammatory bowel disease Mindfulness-based cognitive therapy +5

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.

Molecules June 19, 2023 Ross Van de Wetering, Amy W M Ewald, Susan A Welsh et al.

Kappa opioid receptor (KOR) agonists have preclinical antipsychostimulant effects; however, adverse side effects have limited their therapeutic development. In this preclinical study, conducted in Sprague Dawley rats, B6-SJL mice, and non-human primates (NHPs), we evaluated the G-protein-biased analogue of salvinorin A (SalA), 16-bromo salvinorin A (16-BrSalA), for its anticocaine effects, side...

Psychedelics reopen the social reward learning critical period

Nature June 14, 2023 Romain Nardou, Young Jun Song, Noelle Wright et al. 335 citations

Abstract Psychedelics are a broad class of drugs defined by their ability to induce an altered state of consciousness 1,2 . These drugs have been used for millennia in both spiritual and medicinal contexts, and a number of recent clinical successes have spurred a renewed interest in developing psychedelic therapies 3–9 . Nevertheless, a unifying mechanism that can account for these shared...

The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models

Psychopharmacology June 13, 2023 Mariusz Papp, Piotr Gruca, Magdalena Lason et al.

NLX-101 and NLX-204 are highly selective serotonin 5-HT1A ‘biased’ agonists, displaying potent and efficacious antidepressant-like activity upon acute administration in models such as the forced swim test. we compared the effects of repeated administration of NLX-101, NLX-204 and ketamine in the chronic mild stress (CMS) model of depression, considered to have high translational potential, on...

A regulatory framework review of Schedule I psychedelics in the United States

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY June 12, 2023 Kevin Herkenham 5 citations

Abstract Psychoactive substances such as psilocybin and 3,4‐methylenedioxy‐methamphetamine (MDMA) are currently being investigated for a variety of psychiatric indications including major depressive disorder and post‐traumatic stress disorder. It is critical that clinicians working in the mental health field understand the regulatory framework that balances access and control for such...

Mobile Mindfulness for Psychological Distress and Burnout among Frontline COVID-19 Nurses: A Pilot Randomized Trial

Annals of the American Thoracic Society June 8, 2023 Elias H. Pratt, Levent Hall, Christina Jennings et al. 25 citations

Abstract Rationale The coronavirus disease (COVID-19) pandemic exacerbated psychological distress and burnout in frontline healthcare workers. Interventions addressing psychological distress and burnout among these workers are lacking. Objectives To determine the feasibility and explore the impact of mobile mindfulness to treat psychological distress and burnout among nurses in frontline...